270 related articles for article (PubMed ID: 33528764)
21. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
[TBL] [Abstract][Full Text] [Related]
22. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
23. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
[TBL] [Abstract][Full Text] [Related]
24. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
[TBL] [Abstract][Full Text] [Related]
25. The calcium-sensing receptor and related diseases.
D'Souza-Li L
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):628-39. PubMed ID: 17117288
[TBL] [Abstract][Full Text] [Related]
26. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
Grant MP; Stepanchick A; Breitwieser GE
Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
[TBL] [Abstract][Full Text] [Related]
27. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
28. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1.
Wang X; Lundblad J; Smith SM
PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775
[TBL] [Abstract][Full Text] [Related]
29. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.
Chikatsu N; Fukumoto S; Suzawa M; Tanaka Y; Takeuchi Y; Takeda S; Tamura Y; Matsumoto T; Fujita T
Clin Endocrinol (Oxf); 1999 Apr; 50(4):537-43. PubMed ID: 10468915
[TBL] [Abstract][Full Text] [Related]
30. Three inherited disorders of calcium sensing.
Pollak MR; Seidman CE; Brown EM
Medicine (Baltimore); 1996 May; 75(3):115-23. PubMed ID: 8965680
[TBL] [Abstract][Full Text] [Related]
31. GNA11 Variants Identified in Patients with Hypercalcemia or Hypocalcemia.
Howles SA; Gorvin CM; Cranston T; Rogers A; Gluck AK; Boon H; Gibson K; Rahman M; Root A; Nesbit MA; Hannan FM; Thakker RV
J Bone Miner Res; 2023 Jun; 38(6):907-917. PubMed ID: 36970776
[TBL] [Abstract][Full Text] [Related]
32. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
[TBL] [Abstract][Full Text] [Related]
33. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
[TBL] [Abstract][Full Text] [Related]
34. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
[TBL] [Abstract][Full Text] [Related]
35. [Calcium-sensing receptor and its related diseases].
Aida K; Tawata M; Onaya T
Nihon Rinsho; 1999 Mar; 57(3):746-55. PubMed ID: 10199162
[TBL] [Abstract][Full Text] [Related]
36. Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis.
Livadariu E; Auriemma RS; Rydlewski C; Vandeva S; Hamoir E; Burlacu MC; Maweja S; Thonnard AS; Betea D; Vassart G; Daly AF; Beckers A
Eur J Endocrinol; 2011 Aug; 165(2):353-8. PubMed ID: 21566074
[TBL] [Abstract][Full Text] [Related]
37. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
[TBL] [Abstract][Full Text] [Related]
38. A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.
Gorvin CM; Babinsky VN; Malinauskas T; Nissen PH; Schou AJ; Hanyaloglu AC; Siebold C; Jones EY; Hannan FM; Thakker RV
Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463778
[TBL] [Abstract][Full Text] [Related]
39. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.
Hannan FM; Kallay E; Chang W; Brandi ML; Thakker RV
Nat Rev Endocrinol; 2018 Dec; 15(1):33-51. PubMed ID: 30443043
[TBL] [Abstract][Full Text] [Related]
40. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.
Gorvin CM; Frost M; Malinauskas T; Cranston T; Boon H; Siebold C; Jones EY; Hannan FM; Thakker RV
Hum Mol Genet; 2018 Nov; 27(21):3720-3733. PubMed ID: 30052933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]